What are the Bi-level Positive Airway Pressure (BiPAP) settings for chronic obstructive pulmonary disease (COPD) exacerbation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

For a cold exacerbation, initial BiPAP settings typically include an inspiratory positive airway pressure (IPAP) of 10 cmH2O and expiratory positive airway pressure (EPAP) of 5 cmH2O, as evidenced by a study published in the Annals of Emergency Medicine 1.

Key Considerations

  • The study found that BiPAP patients had a significantly greater increase in peak expiratory flow rate (PEFR) after each treatment, suggesting the effectiveness of BiPAP in managing bronchospasm.
  • The initial settings can be adjusted based on patient response, with the goal of achieving adequate tidal volumes and reducing work of breathing.
  • It is essential to monitor the patient closely, checking arterial blood gases and adjusting the BiPAP settings as needed to ensure optimal ventilation and oxygenation.

Adjusting BiPAP Settings

  • Titrate IPAP upward by 2-3 cmH2O increments to achieve adequate tidal volumes (6-8 mL/kg) and reduce work of breathing, potentially up to 20-25 cmH2O if needed.
  • Maintain the EPAP at 4-6 cmH2O to prevent alveolar collapse and counterbalance intrinsic PEEP.
  • Set the respiratory rate at 12-16 breaths per minute as a backup.

Target Oxygen Saturation

  • Target oxygen saturation between 88-92% for most patients to avoid carbon dioxide retention.
  • Monitor the patient closely for the first 1-2 hours, checking arterial blood gases after 30-60 minutes to assess ventilation effectiveness.

Additional Considerations

  • The use of BiPAP in conjunction with other therapies, such as bronchodilators and corticosteroids, may be beneficial in managing cold exacerbations, as suggested by studies published in Chest 2 and The New England Journal of Medicine 3.
  • A single-inhaler combination therapy for maintenance and relief of asthma may also be an effective strategy in disease management, as endorsed by the Global Initiative for Asthma and supported by studies published in Drugs 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.